Furthermore, univariate and multivariate Cox regression analyses confirmed that PUS7 serves as an independent adverse prognostic factor for PAAD patients (HR = 3.824, 95% CI: 1.475–9.916, p = .006; Table 1; Figure 4F). The gene discussed is PUS7; the disease is pancreatic adenocarcinoma.